ABSTRACT
The increasing device implantations to treat cardiovascular diseases such as arrhytmias and heart failures, aging of the population, and the growing number of patients with access to new therapies as well as the wider access to health systems are the reasons why the number of new implantations carried out each year is rising. Hence, we should have an equipment that can control these patients at a distance, making the follow-up closer. The answer to this enormous challenge is the remote monitoring of these devices. Biotronik is a pioneer in this task and since 2001 it has been comercializing pacemakers and portable wireless monitors (CardioMessenger). Currently, there are more than 100,000 installed systems. Thanks to the continuous and completely automatized follow-up, as well as the wireless net, the system integrity can be confirmed, and then proceed to adjust the therapies in an optimized manner according to each patient's needs; also take action to prevent the development of some arrhytmias, or even the evolution of a heart failure. Likewise, the system can improve the clynical efficiency of the treatment and help to economize to the Ministry of Healthcare.